WHO ICTRP trial
Stem cell therapy in heart failure
EUCTR2015-002929-19-NL · EU Clinical Trials Register · Authorised
Key facts
| Trial ID | EUCTR2015-002929-19-NL |
|---|---|
| Public title | Stem cell therapy in heart failure |
| Scientific title | Stem Cell therapy in IschEmic Non-treatable Cardiac disease - SCIENCE - SCIENCE |
| Primary sponsor | Department of Cardiology, Rigshospitalet |
| Registry | EU Clinical Trials Register |
| Recruitment status | Authorised |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Slovenia;Poland;Denmark;Austria;Germany;Netherlands |
| Conditions | Ischemic heart disease and heart failure MedDRA version: 18.1 Level: LLT Classification code 10019279 Term: Heart failure System Organ Class: 100000004849 ;Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14] |
| Interventions | Product Name: Allogeneic adipose tissue-derived stromal cells Product Code: CSCC_ASC Pharmaceutical Form: Solution for injection INN or Proposed INN: CSCC_ASC Current Sponsor code: SCIENCE Other descriptive name: Ex vivo cultured human… |
| Registration date | Nov 19, 2015 |
| Target size | 139 |
| Secondary IDs | SCIENCE |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: